Resources

Selected
  • Pneumococcal disease
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)
302 results found
2025 ∙ Ngamprasertchai, T. Ruenroengbun, N. Kajeekul, R.
Immunogenicity and Safety of the Higher-Valent Pneumococcal Conjugate Vaccine vs the 13-Valent Pneumococcal Conjugate Vaccine in Older Adults: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Adults Older adults Pneumococcal disease Efficacy/effectiveness Safety Administration
Methodological quality (AMSTAR 2):
Low
2025 ∙ Pacheco-Haro, M. D. de Arenas-Arroyo, S. N. Diaz-Goni, V. Velasco-Lucio, E. J. Castellares-Gonzalez, C. I. Reynolds-Cortez, V. Simeon-Prieto, A. Ignateva, E. Martinez-Vizcaino, V.
Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine Versus a 13-Valent Vaccine in Infants: A Systematic Review and Meta-Analysis
Newborn Pneumococcal disease Efficacy/effectiveness Administration
Methodological quality (AMSTAR 2):
High
2025 ∙ Ul Haq, M. Z. Irfan, H. Shah, M. S. U. Sumbal, A. Mughal, S. Ashraf, S. Basaria, A. A. A. Abdullah, Chacho, M. A. Ayalew, B. D.
Immunogenicity, safety and tolerability of 15-valent pneumococcal conjugate vaccine (V114) compared to 13-valent pneumococcal conjugate vaccine (PCV-13) in healthy infants: A systematic review and meta-analysis
Newborn Pneumococcal disease Efficacy/effectiveness Safety Administration
Methodological quality (AMSTAR 2):
Low
2025 ∙ Regmi, S. Pande, R. Wyatt, T. H. Niederhauser, V.
Impact of COVID-19 on Parental Barriers to Childhood Vaccination: A Systematic Review
Americas United States of America Newborn Children Adolescents Parents/caregivers COVID-19 Hepatitis B Rotavirus Diphtheria Tetanus Pertussis Haemophilus influenzae type B Pneumococcal disease Poliomyelitis Influenza Measles Mumps Rubella Varicella Hepatitis A Acceptance Coverage
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Amare, S. N. Yee, K. C. Leung, M. Naunton, M. Bushell, M.
Impact of pharmacist-led interventions on COVID-19, herpes zoster, influenza, pneumococcal, and respiratory syncytial virus vaccines uptake in people aged 60 years and older: Systematic review and meta-analysis
Adults Older adults Herpes zoster Influenza Pneumococcal disease RSV (Respiratory syncytial virus) COVID-19 Coverage
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Waszkiewicz, M. Wnuk, K. Switalski, J. Augustynowicz, A.
Knowledge, attitudes, and beliefs of pharmacists regarding vaccinations against influenza and pneumococci - a systematic review
Healthcare workers Influenza Pneumococcal disease Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Baiocchi, C. Bhardwaj, M.
Parental vaccine refusal, non-vaccinated children, and outbreaks of Vaccine-Preventable Diseases (VPDs) in Europe: a systematic review of aetiology and risk
Europe Newborn Children Adolescents Parents/caregivers Diphtheria Haemophilus influenzae type B Hepatitis B Human papillomavirus (HPV) Measles Rubella Mumps Pertussis Pneumococcal disease Poliomyelitis Tetanus Acceptance Coverage
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Mariscal-Lopez, E. Agredano-Sanchez, M. Lopez-Gigosos, R. M. Mariscal, A. Farinas-Guerrero, F. Gutierrez-Bedmar, M. Guts-Chornoknyzha, M.
Protective effect of adult vaccination on the development of dementias: A systematic review
Adults Older adults Influenza Tetanus Diphtheria Pertussis Herpes zoster Pneumococcal disease Tuberculosis Rabies Hepatitis A Typhoid Hepatitis B Efficacy/effectiveness Safety Administration
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Cho, J. Y. Lee, H. Wannaadisai, W. Vietri, J. Chaiyakunapruk, N.
Systematic literature review of cost-effectiveness analyses of adult 15- and 20-valent pneumococcal vaccines
Adults Older adults Pneumococcal disease Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Holland, C. Oakes, D. Sarna, M. Chai, K. Ng, L. Moore, H. C.
Systematic review and meta-analysis of the non-specific and broader impact of respiratory vaccines on acute lower respiratory infections in young children
Newborn Children Pregnant women Influenza Haemophilus influenzae type B RSV (Respiratory syncytial virus) Measles Pneumococcal disease Diphtheria Tetanus Pertussis Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
Loading...